Israel's IceCure Medical Ltd., which develops cryoablation technology that destroys tumors by freezing without the need for surgery, will be presenting at the H.C. Wainwright Global Life Sciences Conference, to be held virtually from March 9-10, 2021.
Follow Israel Hayom on Facebook and Twitter
IceCure Medical will be presenting information on its flagship ProSense System, which the company reports destroys tumors safely, quickly, and painlessly.
"I am delighted to be able to participate in H.C. Wainwright's virtual event, that will truly reach a global audience in order to advance investment in the field of life science," said IceCure Medical CEO Eyal Shamir.
The presentation, by Shamir and COO Ronen Tsmierman, will be available on-demand through the H.C. Wainwright conference portal, starting at 7 a.m. EST on Tuesday, March 9.
